| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/23/1991 | WO1991009947A1 Polypeptides having serine protease inhibitor activity and dna coding therefor |
| 06/23/1991 | WO1991009946A1 Method of preparation of hirudin |
| 06/23/1991 | WO1991009871A1 Hybrid molecules having translocation region and cell-binding region |
| 06/23/1991 | CA2071969A1 Hybrid molecules having translocation region and cell-binding region |
| 06/23/1991 | CA2070399A1 Polypeptides and dna coding therefor |
| 06/23/1991 | CA2066442A1 Method of preparation of hirudin |
| 06/22/1991 | WO1991009968A1 Cd3 specific recombinant antibody |
| 06/22/1991 | WO1991009965A1 An improved toxin for construction of immunotoxins |
| 06/22/1991 | CA2071946A1 Toxin for construction of immunotoxins |
| 06/22/1991 | CA2032607A1 Separation material for blood coagulation factor' preparation and use thereof |
| 06/19/1991 | EP0432965A1 Malaria vaccine |
| 06/19/1991 | EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use |
| 06/19/1991 | CN1052310A Hiv related peptides |
| 06/16/1991 | CA2031831A1 Production method for foreign protein |
| 06/14/1991 | CA2071858A1 Hiv-1 env fragment fusion protein |
| 06/13/1991 | WO1991008483A1 Endothelial-derived il-8 |
| 06/13/1991 | WO1991008482A1 Antibody variable domain conjugates |
| 06/13/1991 | WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 06/13/1991 | WO1991008231A1 [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR |
| 06/12/1991 | EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 06/09/1991 | CA2031468A1 Malaria vaccine |
| 06/08/1991 | WO1991009125A1 Proteins and nucleic acids |
| 06/08/1991 | WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins |
| 06/08/1991 | CA2069105A1 Proteins and nucleic acids |
| 06/05/1991 | EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component |
| 06/05/1991 | EP0429628A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| 06/05/1991 | EP0429611A1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
| 06/05/1991 | EP0429484A1 Porcine polyclonal and monoclonal antibodies |
| 06/05/1991 | EP0394291A4 Means for diagnosing arc and aids |
| 05/30/1991 | WO1991007979A1 Chimeric proteins |
| 05/30/1991 | WO1991007437A2 Improved cd-30 antibodies and fragments thereof |
| 05/30/1991 | CA2069106A1 Chimeric proteins |
| 05/29/1991 | WO1991007985A1 Monoclonal antibody which distinguishes helper inducer and supressor inducer ce4+ lymphocytes |
| 05/28/1991 | US5019521 Paired polypeptides |
| 05/28/1991 | US5019500 IGF-I fusion proteins; protection of IGF-I from degradation by host cell proteases; and processes for the production thereof |
| 05/28/1991 | CA1284507C Melphalan derivatives |
| 05/22/1991 | EP0428188A2 Novel immunoconjugates and methods for their use in tumor therapy |
| 05/18/1991 | WO1991007490A1 Protein complexes having factor viii:c activity and production thereof |
| 05/18/1991 | CA2135744A1 Protein complexes having factor viii:c activity and production thereof |
| 05/18/1991 | CA2068728A1 Protein complexes having factor viii:c activity and production thereof |
| 05/16/1991 | WO1991006648A1 Glutamate receptor compositions and methods |
| 05/16/1991 | WO1991006568A1 High molecular weight human angiogenic factors |
| 05/16/1991 | WO1991006319A1 Methods and compositions for promoting immunopotentiation |
| 05/16/1991 | CA2071478A1 Methods and compositions for promoting immunopotentiation |
| 05/15/1991 | EP0426838A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 05/15/1991 | EP0426787A1 POLYPEPTIDE RESULTING FROM THE FUSION BETWEEN A MALTOSE-RELATED COMPOUND (MalE) AND A CD4 FRAGMENT FOR NEUTRALIZING THE AIDS VIRUS |
| 05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
| 05/14/1991 | WO1991007664A1 Diagnostic proteins to test for more than one antibody |
| 05/14/1991 | WO1991007494A1 Chimeric mouse human antibodies with specificity to hiv antigens |
| 05/14/1991 | WO1991007482A1 Type-b rotavirus cultures and uses thereof |
| 05/14/1991 | WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| 05/14/1991 | CA2068520A1 Type-b rotavirus cultures and uses thereof |
| 05/14/1991 | CA2045524A1 Diagnostic proteins to test for more than one antibody |
| 05/14/1991 | CA2044627A1 Chimeric mouse human antibodies with specificity to hiv antigens |
| 05/14/1991 | CA2044609A1 Chimeric mouse human antibodies with specificity to hiv antigens |
| 05/14/1991 | CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| 05/08/1991 | WO1991006305A1 Oligomeric immunoglobulins |
| 05/08/1991 | EP0426314A2 HIV related peptides |
| 05/08/1991 | CA2045150A1 Oligomeric immunoglobulins |
| 05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |
| 05/02/1991 | EP0425082A1 Bordetella vaccines |
| 05/02/1991 | EP0424748A1 Synthetic envelope peptides of HTLV-I |
| 05/02/1991 | EP0424519A1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship. |
| 05/02/1991 | EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 05/01/1991 | WO1991006652A1 Outer membrane protein p1 and peptides of haemophilus influenzae type b |
| 05/01/1991 | CA2027317A1 Vaccine composition with non-immunosuppressive t-cell epitope component |
| 04/28/1991 | WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
| 04/28/1991 | CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use |
| 04/25/1991 | WO1991006647A1 Gastrin releasing peptide receptor |
| 04/25/1991 | WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor |
| 04/25/1991 | CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor |
| 04/25/1991 | CA2067766A1 Gastrin releasing peptide receptor |
| 04/24/1991 | EP0423315A1 Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine |
| 04/24/1991 | CA2028172A1 Synthetic envelope peptides of htlv-i |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 04/17/1991 | EP0422215A1 Antibacterial and antimalarial peptides |
| 04/17/1991 | EP0422037A1 Immunochemical assay for human granulocyte-macrophage colony stimulating factor |
| 04/16/1991 | CA1283045C Therapeutic and diagnostic methods using soluble t cell surface molecules |
| 04/13/1991 | CA2027455A1 Hiv related peptides |
| 04/10/1991 | EP0421876A1 Use of active agents in the preparation of a drug for the treatment of lymphomes or related diseases |
| 04/10/1991 | EP0421635A1 Chimaeric hepadnavirus core antigen proteins |
| 04/10/1991 | EP0421626A1 Vaccine for aids and hepatitis B |
| 04/10/1991 | EP0420911A1 Gene therapy using gene fusions for genetic or acquired disorders. |
| 04/09/1991 | US5006652 Intermediates for antibody-vinca drug conjugates |
| 04/09/1991 | US5006459 Immunoassays |
| 04/09/1991 | CA1282691C Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease |
| 04/07/1991 | CA2027077A1 Application of active substances for the preparation of a drug for the treatment of lymphomas or related diseases, the drugs thus obtained and a process for the therapeutic treatment of lymphomas |
| 04/04/1991 | WO1991004490A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 04/04/1991 | WO1991004272A1 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/04/1991 | WO1991000100A3 Toxin uses |
| 04/03/1991 | EP0420043A1 Antibodies against highly conservated amino acid sequences of immunogenic substances, process of preparation of these antibodies and their use as immunoessays |
| 04/03/1991 | EP0419576A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 04/02/1991 | US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides |
| 04/02/1991 | US5004686 Process for producing human epidermal growth factor and analogs thereof |
| 03/27/1991 | EP0418827A1 Vaccine against Lyme disease |
| 03/27/1991 | EP0418626A2 Fused proteins and production thereof |
| 03/27/1991 | EP0418316A1 Platelet-specific chimeric immunoglobulin |
| 03/27/1991 | EP0209586B1 Anti-histamine antibody preparation with specificity for a 4-(2-aminoethyl)imidazolyl group attached directly to an alkylene chain and immunoassay method employing the preparation |
| 03/26/1991 | CA1282021C Particulates having the immunogenic power of the hbs antigen and carrying an antigenic site foreign to the epitopes carried by the hbs antigen; vectors and animal cells for the production of such particulates and compositions containing such particulates for the production of mixed vaccines |